The association of an HPV16 oncogene variant with HLA-B7 has implications for vaccine design in...

7
© 1995 Nature Publishing Group http://www.nature.com/naturemedicine

Transcript of The association of an HPV16 oncogene variant with HLA-B7 has implications for vaccine design in...

Page 1: The association of an HPV16 oncogene variant with HLA-B7 has implications for vaccine design in cervical cancer

© 1995 Nature Publishing Group http://www.nature.com/naturemedicine

Page 2: The association of an HPV16 oncogene variant with HLA-B7 has implications for vaccine design in cervical cancer

© 1995 Nature Publishing Group http://www.nature.com/naturemedicine

Page 3: The association of an HPV16 oncogene variant with HLA-B7 has implications for vaccine design in cervical cancer

© 1995 Nature Publishing Group http://www.nature.com/naturemedicine

Page 4: The association of an HPV16 oncogene variant with HLA-B7 has implications for vaccine design in cervical cancer

© 1995 Nature Publishing Group http://www.nature.com/naturemedicine

Page 5: The association of an HPV16 oncogene variant with HLA-B7 has implications for vaccine design in cervical cancer

© 1995 Nature Publishing Group http://www.nature.com/naturemedicine

Page 6: The association of an HPV16 oncogene variant with HLA-B7 has implications for vaccine design in cervical cancer

© 1995 Nature Publishing Group http://www.nature.com/naturemedicine

Page 7: The association of an HPV16 oncogene variant with HLA-B7 has implications for vaccine design in cervical cancer

© 1995 Nature Publishing Group http://www.nature.com/naturemedicine


Dominant-negative missense p53 gene mutation Upstream tumour suppressor gene mutation (ATM) Oncogene amplification (MDM2) Viral oncogene.

Dominant-negative missense p53 gene mutation Upstream tumour suppressor gene mutation (ATM) Oncogene amplification (MDM2) Viral oncogene.

INTERACTION STUDIES BETWEEN TRUNCATED HPV16/18 …eprints.usm.my/31580/1/Fatin_Athirah.pdf · INTERACTION STUDIES BETWEEN TRUNCATED HPV16/18 E7 ONCOPROTEIN WITH CTCF/YB-1 TRANSCRIPTION

INTERACTION STUDIES BETWEEN TRUNCATED HPV16/18 …eprints.usm.my/31580/1/Fatin_Athirah.pdf · INTERACTION STUDIES BETWEEN TRUNCATED HPV16/18 E7 ONCOPROTEIN WITH CTCF/YB-1 TRANSCRIPTION

In-Silico Studies of Oncogene Protein with Anti-Cancer Drugs3)14/3.pdf · 2019-08-02 · In-Silico Studies of Oncogene Protein with Anti-Cancer Drugs ... An oncogene protein (PDB

In-Silico Studies of Oncogene Protein with Anti-Cancer Drugs3)14/3.pdf · 2019-08-02 · In-Silico Studies of Oncogene Protein with Anti-Cancer Drugs ... An oncogene protein (PDB

0319 RET Proto-Oncogene Testing - Aetna

0319 RET Proto-Oncogene Testing - Aetna

Effect of Pap Smear Collection on Cervicovaginal HPV16 ...

Effect of Pap Smear Collection on Cervicovaginal HPV16 ...

Oncogene & oncogenese

Oncogene & oncogenese

Open access Original research Oncogene-specific ...

Open access Original research Oncogene-specific ...

F 69 HLA F 78 HLA F 90 HLA F 101 HLA - Ziegler · 2018. 4. 20. · Bronto Skylift’s HLA Range represents the ultimate in high rise rescue and fi re fi ghting capability. This

F 69 HLA F 78 HLA F 90 HLA F 101 HLA - Ziegler · 2018. 4. 20. · Bronto Skylift’s HLA Range represents the ultimate in high rise rescue and fi re fi ghting capability. This

Oncogene Review

Oncogene Review

YMA Khawhar Hla Bu (Thalai Hla te)

YMA Khawhar Hla Bu (Thalai Hla te)

Oncogene-1998-Di Como-2527-39

Oncogene-1998-Di Como-2527-39

The Royal Society of Chemistry · 25 amplified using primer pair F (HPV16)/R (HPV16) (Table S10), followed by splitting into nine portions and incubation at 95°C with nine groups

The Royal Society of Chemistry · 25 amplified using primer pair F (HPV16)/R (HPV16) (Table S10), followed by splitting into nine portions and incubation at 95°C with nine groups

Methylation status of the E2 binding sites of HPV16 in ... · Methylation status of the E2 binding sites of HPV16 in cervical lesions determined with the Luminex® xMAP™ system

Methylation status of the E2 binding sites of HPV16 in ... · Methylation status of the E2 binding sites of HPV16 in cervical lesions determined with the Luminex® xMAP™ system

Oncogene Addiction versus Oncogene Amnesia: …...Perhaps the most compelling evidence that cancer can be reversed through oncogene inactivation came from studies performed using conditional

Oncogene Addiction versus Oncogene Amnesia: …...Perhaps the most compelling evidence that cancer can be reversed through oncogene inactivation came from studies performed using conditional

Anticorpos anti-HLA no transplante cardíaco Encontro... · 2020-03-03 · POLIMORFISMO HLA Numbers of HLA Alleles HLA Class I Alleles 12,021 HLA Class II Alleles 4,230 HLA Alleles

Anticorpos anti-HLA no transplante cardíaco Encontro... · 2020-03-03 · POLIMORFISMO HLA Numbers of HLA Alleles HLA Class I Alleles 12,021 HLA Class II Alleles 4,230 HLA Alleles

HLA-DR4 · PDF fileLikewise, the subtypes of HLA-DR4 were established by ... HLA-DRtypingobtainedbySSOprobeswerevalidatedin45 subjectspreviouslytypedbythestandardNationalInstitutes

HLA-DR4 · PDF fileLikewise, the subtypes of HLA-DR4 were established by ... HLA-DRtypingobtainedbySSOprobeswerevalidatedin45 subjectspreviouslytypedbythestandardNationalInstitutes

Small Molecules Targeting c-Myc Oncogene: Promising Anti ... · Small Molecules Targeting c-Myc Oncogene: Promising Anti ... ... p ...

Small Molecules Targeting c-Myc Oncogene: Promising Anti ... · Small Molecules Targeting c-Myc Oncogene: Promising Anti ... ... p ...

IMMUNOGENETIC TESTS. MHC = Major histocompability complex HLA = Human lymphocyte antigen HLA class I: HLA-A, B and C Present on all nucleated cells HLA.

IMMUNOGENETIC TESTS. MHC = Major histocompability complex HLA = Human lymphocyte antigen HLA class I: HLA-A, B and C Present on all nucleated cells HLA.

Tumor Suppressor Gene & Proto-Oncogene

Tumor Suppressor Gene & Proto-Oncogene

Oncogene etc

Oncogene etc